Vector Manufacturing
Source: Cell & Gene
In this segment, Cartesian Therapeutics SVP and head of manufacturing operations, Emily English, Ph.D., explains the company’s unique mRNA-based approach to CAR-T manufacturing. The panelists also discuss how vector supply can impact CAR-T production.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
This website uses cookies to ensure you get the best experience on our website. Learn more